1. Home
  2. USNA vs EDIT Comparison

USNA vs EDIT Comparison

Compare USNA & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$22.71

Market Cap

397.1M

Sector

Health Care

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.87

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
EDIT
Founded
1992
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.1M
432.8M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
USNA
EDIT
Price
$22.71
$2.87
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$5.30
AVG Volume (30 Days)
97.6K
2.9M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.50
EPS
0.41
N/A
Revenue
$1,060,902,000.00
$31,937,000.00
Revenue This Year
$3.90
N/A
Revenue Next Year
$6.21
N/A
P/E Ratio
$54.70
N/A
Revenue Growth
N/A
132.64
52 Week Low
$16.60
$1.66
52 Week High
$38.32
$4.54

Technical Indicators

Market Signals
Indicator
USNA
EDIT
Relative Strength Index (RSI) 65.03 42.48
Support Level $18.71 $2.77
Resistance Level $22.64 $3.27
Average True Range (ATR) 1.01 0.26
MACD 0.06 -0.05
Stochastic Oscillator 85.97 10.50

Price Performance

Historical Comparison
USNA
EDIT

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: